Impact of Octreotide Scintigraphy on the Management of Neuroendocrine Tumours

被引：0
|
作者：
Koc, T. [1 ]
Franklin, J. [1 ]
Miles, K. [1 ]
Webb, A. [1 ]
Dizdarevic, S. [1 ]
机构：
[1] Brighton & Sussex Univ Hosp, Brighton, E Sussex, England
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2009年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S365 / S365
页数：1
相关论文
共 50 条
  • [41] Everolimus in the management of metastatic neuroendocrine tumours
    Chan, David L.
    Segelov, Eva
    Singh, Simron
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2017, 10 (01): : 132 - 141
  • [42] SURGICAL MANAGEMENT OF DUODENAL NEUROENDOCRINE TUMOURS
    Pizanias, Michail
    Kontis, Elissaios
    Barbouti, Omar
    Prassas, Evangelos
    Ramage, John
    Prachalias, Andreas
    Srirajaskanthan, Rajaventhan
    GUT, 2018, 67 : A157 - A157
  • [43] Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours
    Nilsson, O
    Kölby, L
    Wängberg, B
    Wigander, A
    Billig, H
    William-Olsson, L
    Fjälling, M
    Forssell-Aronsson, E
    Ahlman, H
    BRITISH JOURNAL OF CANCER, 1998, 77 (04) : 632 - 637
  • [44] Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours
    O Nilsson
    L Kölby
    B Wängberg
    A Wigander
    H Billig
    L William-Olsson
    M Fjälling
    E Forssell-Aronsson
    H Ahlman
    British Journal of Cancer, 1998, 77 : 632 - 637
  • [45] Somatostatin receptors scintigraphy and chromogranin A(CGA) serum levels in neuroendocrine tumours
    Cimitan, M
    Borsatti, E
    Buonadonna, A
    Cannizzaro, R
    Ruffo, R
    Canzonieri, V
    De Apollonia, L
    Bò, N
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 1178 - 1178
  • [46] High Grade Neuroendocrine Tumours : Value of 111In-pentetreotide Scintigraphy
    Slim, I.
    Meddeb, I.
    Limam, K.
    Yeddes, I.
    El Bez, I.
    Ben Ghachem, T.
    Mhiri, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S471 - S471
  • [47] Concordance between results of somatostatin receptor scintigraphy with 111In-DOTA-DPhe1-Tyr3-octreotide and chromogranin A assay in patients with neuroendocrine tumours
    Rodrigues, Margarida
    Gabriel, Michael
    Heute, Dirk
    Putzer, Daniel
    Griesmacher, Andrea
    Virgolini, Irene
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (10) : 1796 - 1802
  • [48] Concordance between results of somatostatin receptor scintigraphy with 111In-DOTA-DPhe1-Tyr3-octreotide and chromogranin A assay in patients with neuroendocrine tumours
    Margarida Rodrigues
    Michael Gabriel
    Dirk Heute
    Daniel Putzer
    Andrea Griesmacher
    Irene Virgolini
    European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35
  • [49] Impact of 111In-DTPA-octreotide SPECT/CT fusion images in the management of neuroendocrine tumours [Impatto della fusione di immagini SPECT/TC con 111In-DTPA- octreotide nel management dei tumori neuroendocrini]
    Castaldi P.
    Rufini V.
    Treglia G.
    Bruno I.
    Perotti G.
    Stifano G.
    Barbaro B.
    Giordano A.
    La radiologia medica, 2008, 113 (7) : 1056 - 1067
  • [50] 111IN-OCTREOTIDE SCINTIGRAPHY IN PATIENTS AFFECTED BY NEUROENDOCRINE TUMORS: CORRELATION WITH TUMOR MARKERS
    Chiapperino, Cosima
    Martino, Maria Teresa
    Grassadonia, Antonino
    Iurisci, Ida
    Deligiannis, Panagiotis
    Iacobelli, Stefano
    ANNALS OF ONCOLOGY, 2004, 15 : 85 - 85
12345